Diagnostic and Prognostic Value of Platelet Indices in Acute Ischemic Stroke: A Retrospective Analysis
The European Research Journal · 2026-12-01 · 1365-1375
DOI: 10.18621/eurj.1421 ↗Abstract
Objective: Platelet indices are routinely available, but their diagnostic value in patients with stroke-suggestive symptoms remains uncertain. This study evaluated the diagnostic and prognostic performance of these indices in an emergency department population. Methods: This retrospective study included adults who underwent neurology consultation between June 1, 2023, and June 1, 2026. Eligible patients had stroke-suggestive symptoms, relevant neuroimaging, and complete blood count data. Patients were classified as having acute ischemic stroke (AIS), transient ischemic attack (TIA), or nonstroke presentation. Platelet count, mean platelet volume (MPV), plateletcrit, platelet distribution width, and their derived ratios were analyzed. Diagnostic performance was assessed using receiver operating characteristic curve analysis and logistic regression. Thirty-day mortality was evaluated among patients with ischemic cerebrovascular events. Results: Of 4218 screened patients, 1079 were included: 799 nonstroke, 256 AIS, and 24 TIA. None of the platelet parameters differed significantly between the nonstroke and combined stroke/TIA groups. Area under the curve (AUC) values ranged from 0.50 to 0.51. None of the parameters remained significantly associated with ischemic cerebrovascular events after adjustment for age, sex, hypertension, diabetes mellitus, and previous stroke. MPV was lower in 30-day nonsurvivors than in survivors (median [IQR], 10.6 [9.7-11.1] fL vs 11.1 [10.3-11.8] fL; P = .049); however, this association was based on univariable analysis only because the limited number of mortality events (n = 16) precluded reliable multivariable analysis. Conclusions: Platelet parameters did not provide clinically meaningful diagnostic discrimination between ischemic cerebrovascular events and nonstroke presentations. The isolated association between lower MPV and 30-day mortality was exploratory and should be interpreted cautiously.
EUVIMED